In Vitro Evaluation of Antibacterial, Antioxidant, and Antidiabetic Activities and Glucose Uptake through 2-NBDG by Hep-2 Liver Cancer Cells Treated with Green Synthesized Silver Nanoparticles

Majeed, Shahnaz; Danish, Mohammed; Zakariya, Norul Aini; Hashim, Rokiah; Ansari, Mohammed Tahir; Alkahtani, Saad; Hasnain, Md Saquib

doi:https://doi.org/10.1155/2022/1646687

Oxidative Medicine and Cellular Longevity

On this page

Abstract Introduction Methods Discussion Conclusion Data Availability Conflicts of Interest Acknowledgments References Copyright Related Articles

Special Issue

Redox Biology in Diabetes

View this Special Issue

Research Article | Open Access

Volume 2022 | Article ID 1646687 | https://doi.org/10.1155/2022/1646687

In Vitro Evaluation of Antibacterial, Antioxidant, and Antidiabetic Activities and Glucose Uptake through 2-NBDG by Hep-2 Liver Cancer Cells Treated with Green Synthesized Silver Nanoparticles

Shahnaz Majeed,¹Mohammed Danish,²Norul Aini Zakariya,¹Rokiah Hashim,²Mohammed Tahir Ansari,³Saad Alkahtani,⁴and Md Saquib Hasnain⁵

Academic Editor: Swayam Srivastava

Received15 Jan 2022

Revised08 Mar 2022

Accepted09 Apr 2022

Published17 May 2022

Abstract

The alarming rise in diabetes owing to drug resistance necessitates the implementation of prompt countermeasures in the treatment module of diabetes. Due to their unique physicochemical features, silver nanoparticles may have potential applications in the medical and pharmaceutical industries. Silver nanoparticles (AgNPs) were synthesized from the culture filtrate of Salmonella enterica (ATCC-14028). UV-Vis spectrophotometry, FTIR, SEM, and energy dispersive X-rays were used in the characterization of the nanoparticles. Transmission electron microscopy (TEM) revealed that AgNPs are spherical and highly scattered and vary in size from 7.18 nm to 13.24 nm. AgNP stability and protein loss were confirmed by thermogravimetric analysis (TGA) at different temperatures. The AgNPs had excellent antibacterial activity and a strong synergistic effect against methicillin-resistant bacteria Staphylococcus aureus (MRSA) ATCC-4330 and Streptococcus epidermis (MRSE) ATCC-51625. The DPPH experiment revealed that the AgNPs had high antioxidant activity. The antidiabetic assay revealed that these AgNPs had an IC50 for alpha-amylase of 428.60 μg/ml and an IC50 for alpha-glucosidase of 562.02 μg/ml. Flow cytometry analysis of Hep-2 cells treated with AgNPs (40 μg/ml) revealed higher expression of 2-NBDG glucose absorption (uptake) compared to control metformin. These AgNPs have promising antidiabetic properties and could be used in pharmaceuticals and biomedical industries.

1. Introduction

The branch of nanobiotechnology deals with particles in the size range of 1 to 100 nm. Nanoparticles have been reported to be used in a variety of fields, including engineering, medicine, pharmaceuticals, and textiles [1–3]. Metallic nanoparticles, particularly platinum, silver, and gold, have been studied for a wide range of applications including antibacterial, antifungal, anticancer, catalysis, and electronics [4]. Among these nanoparticles, silver nanoparticles have recently piqued the interest of researchers due to their unique chemical and physical properties, particularly in the electrical, thermal, catalysis, industrial, and biomedical fields [5, 6]. AgNPs have potential applications in medical device coating, sensors, the ph5armaceutical industry, drug delivery, orthopaedics, and oncology [7]. It is also possible to alter the physical, biological, and chemical properties of metallic nanoparticles because they have a low surface area-to-volume ratio [8]. Study shows that the silver nanoparticles from the Hypnea valentiae exhibited outstanding antioxidant, antibacterial, and anticancer properties [9].

Diabetes mellitus is a serious metabolic disorder characterized by elevated glucose levels in the blood that can be acute or chronic [10]. Increased appetite, frequent urination, and increased thirst are the most common symptoms. Diabetes mellitus, if left untreated, can lead to serious health problems such as chronic kidney disease, stroke, cancer, neuropathy, vision loss, and cardiovascular disease [11]. Diabetes mellitus affects people in both developed and developing countries, with estimates indicating that about 25% of the world’s population is affected [12]. Most of the antidiabetic drugs such as sulphonylurea, alpha-glucosidase inhibitors, biguanides, and thiazolidinediones decrease the glucose level in the body. Secretagogues like sulfonylurea depolarize the cell membrane, enabling influx of calcium ions into the beta cells and hence increasing insulin secretion from the secretory granules [13]. Although antidiabetic drugs have been used for a long time, the biggest concern with them is that diabetic patients are developing drug resistance and suffering from drug toxicity, weight gain, gastrointestinal disturbance, lactic acidosis, and, in some cases, liver disease [14, 15].

Studies have reported the use of nanotechnology in management of diabetes. The nanoparticles can be used to develop glucose sensor technology capable of measuring the accurate glucose level in the body [16, 17]. Controlled insulin delivery is possible with nanomedicine because it can detect changes in the blood glucose levels and automatically control the release of insulin to keep the blood glucose levels normal [18]. Nanoparticulate cancer drugs, such as Abraxane, Onivyde, and Doxil, may improve the efficacy of drug delivery to target sites [19, 20]. The current research will help to explore the function of AgNPs that will help in delivering the drugs to the target site by conjugating the nanoparticles with available commercial drugs, which would be more potent to produce biological efficacy.

The broad applications of AgNPs have been explored, such as catalysis, dye reduction, antimicrobial, anticancer, and household goods. As a result, it piques the interest of researchers to investigate more and more applications for synthesizing AgNPs. There are various methods for the synthesis of AgNPs, such as physical, chemical, and biological methods. Both physical and chemical methods have been found to be extremely time-consuming, expensive, and potentially harmful to the environment and human health [21, 22]. The biological method, which employs fungi, bacteria, plants, and algae as nanofactories, has been shown to be nontoxic, environmentally friendly, and cost-effective, and it has a wide range of applications in biomedical, industrial, and pharmaceutical settings [23, 24].

There is a lack of data to explain how AgNPs will improve glucose uptake in Hep-2 cells. This project is aimed at synthesizing AgNPs from Salmonella enterica and exploring its antioxidant, antidiabetic, and antibacterial effects. The synthesized AgNPs were characterized using UV-Vis spectroscopy, FTIR, TGA, and SEM/EDX/TEM and were found to be consistent with previous studies. The study also examined the effects of AgNPs on the enzymatic activity of alpha-glucosidase and alpha-amylase. Flow cytometry was used to study glucose absorption in treated Hep-2 liver cancer cells, and the antibacterial activity was carried out against MRSA and MRSE using the disc diffusion method.

2. Material and Methods

2.1. Chemical and Reagents

Silver nitrate (AgNO₃), nutrient agar media, DMEM-low glucose, foetal bovine serum, and MTT reagent were procured from HiMedia, Malaysia. Metformin and DMSO were obtained from Sigma-Aldrich, Bangalore, India.

2.2. Cell Line and Bacteria Culture

The Hep-2 cell line was purchased from the National Centre of Cell Science Studies (NCCS), Pune, India, and Salmonella enterica was procured from American Type Culture Collection (ATTC).

2.3. Synthesis of AgNPs from Salmonella enterica

Salmonella enterica was cultured overnight in 100 mL nutrient agar broth in a 200 mL conical flask at 37°C. The following day, the culture was centrifuged for 10 minutes at 3000 rpm. The pellet was discarded, and the supernatant was transferred to another conical flask. The supernatant was used to synthesize AgNPs. 1 mM silver nitrate was added dropwise to the supernatant solution with constant stirring for 1 hour at room temperature (30°C). After adding the silver nitrate, the flask was placed on an orbital shaker for 12 hours to allow complete reduction of the silver nitrate. The colour change confirms that silver ions have been reduced to silver nanoparticles.

2.4. Characterization of AgNPs

An accurately measured 100 μL of AgNP solution was suitably diluted with double-distilled water (dH₂O), and the sample was scanned from 300 to 600 nm using a UV-visible spectrophotometer (Shimadzu-80712, Japan). The potassium bromide (KBR) pellet method was used for the FTIR analysis. Solid AgNPs were mixed with KBR (1 : 10) and pressed into a solid pellet, and FTIR spectra were analyzed (Shimadzu IRPRESTIGE 21, Japan). AgNP sample spectrum was collected by 64 scans aggregating from the 4000 cm^-1 to 400 cm^-1 wave region. The protein and other component loss at different temperatures was analyzed using thermogravimetric analysis (TGA) (Mettler Toledo, Switzerland). The sample was placed on an aluminium pan, and the analysis was performed at a heating rate of 10°C per minute. The liquid AgNP solution was dried at 60°C for 5 days, and the dried sample was subjected to surface morphological analysis using FESEM (FEI Quanta FEG 650, Thermo Fisher Scientific, Netherlands) and for the elemental nature of silver using EDX (Oxford Instrument, Model X-Max). The AgNP solution was sonicated for 5 minutes and then placed on a copper-coated grid for shape, size, and polydispersity index using TEM analysis using Libra 120 (Carl Zeiss, Germany).

2.5. Determination of the Antibacterial Activity of Drug-Resistant MRSA and MRSE

The disc diffusion method was used to test the antibacterial activity of biosynthesized AgNPs on nutrient agar media. A 2-hour old MRSA and MRSE bacterial culture was inoculated and swabbed on nutrient agar medium. The blank discs were placed on the nutrient agar plate and AgNPs were then impregnated at a concentration of 10, 20, 30, and 40 μg/ml, respectively, and the results were compared to the positive control vancomycin. The zone of inhibition was recorded after overnight incubation at 37°C.

2.6. Determination of Synergistic Effect

The synergistic effect was evaluated along with the different antibiotics such as vancomycin, ceftriaxone, and gentamycin. Antibiotic discs were impregnated with 20 μg/ml of AgNPs, and a zone of inhibition was recorded after 8 h of incubation. The experiment was repeated three times.

2.7. Evaluation of the Antioxidant Activity of AgNPs through the DPPH Assay

The antioxidant activity of AgNPs was determined using the DPPH (1,1-diphenyl-2-picrylhydrazyl) test. Varying concentrations of AgNPs, starting from 10 μg/ml to 40 μg/ml, were dissolved in the DPPH solution [25]. Ascorbic acid was used as a positive control. The antioxidant activity was measured by the colour shift from purple to yellow after the addition of AgNPs, which is caused by the absorption of hydrogen atoms. Absorption was recorded using a spectrophotometer, and DPPH inhibition was calculated using the formula below.

where Ac is the average absorbance for the control (ascorbic acid) and As is the absorbance for the sample (AgNPs).

2.8. Evaluation of the Antidiabetic Activity of AgNPs

2.8.1. Determination of Alpha-Amylase Enzyme Inhibition

The starch solution (0.1% ) was prepared by stirring 0.1 g of potato starch in 100 ml of 16 mM sodium acetate buffer. Subsequently, the enzyme solution was prepared by mixing 27.5 mg of alpha-amylase into 100 ml of double-distilled water. The colorimetric reagent was prepared by mixing sodium potassium tartrate solution and 3,5-di nitro salicylic acid solution (96 mM). Next, starch was added to the control and AgNP solution (five concentrations: 62.5, 125, 250, 500, and 1000 μg/ml) and left as such so that alpha-amylase reacts at 25°C and the reaction was measured in 3 minutes. The positive control used in this study was acarbose. The maltose production was quantified by reducing 3,5-dinitro salicylic acid to 3-amino-5-nitro salicylic acid [26]. The whole reaction was detected at 540 nm using an ELISA reader. The inhibition () of alpha-amylase was calculated using the formula below:

where is the inhibition percentage and As, Ab, and Ac are the average absorbance of the sample, blank, and control, respectively.

2.8.2. Evaluation of the Alpha-Glucosidase Enzyme Inhibition

The AgNP solutions at concentrations of 62.5, 125, 250, 500, and 1000 μg/ml were mixed with starch substrate solution (2% maltose or sucrose) in the presence of 0.2 M Tris buffer at pH 8.0 and incubated for 5 min at 37°C. Subsequently, 1 ml of the alpha-glucosidase enzyme (1 U/ml) was added and incubated at 35°C for 40 min [26]. The reaction was terminated with the addition of 2 ml of 6 N HCl. Voglibose was used as a standard control. The colour intensity was measured at 540 nm using an ELISA reader, and alpha-glucosidase enzyme inhibition () was calculated using the formula below:

where is the inhibition percentage and As, Ab, and Ac are the average absorbance of the sample (AgNPs), blank, and control (voglibose), respectively.

2.8.3. Evaluation of the Anticancer Activity on Hep-2 Liver Cancer Cells through the MTT Assay

A total of nearly 200 μl of Hep-2 cells were seeded in a 96-well plate to get a cell density of 20,000 cells per well and allowed to grow for 24 h under a carbon dioxide environment. Varying concentrations of AgNPs 10, 20, 40, 60, and 80 μg/ml were added to the cells, and the whole plate was then incubated for 24 h at 37°C in an atmosphere of 5% CO₂. After incubation, the spent media were removed and the MTT reagent to a concentration of 0.5 mg/mL of total volume was added. The entire plate was wrapped with aluminium foil to avoid light exposure and incubated for 3 minutes. The MTT reagent was removed, and 100 μl of solubilization solution (DMSO) was added. The whole plate was stirred gently on a gyratory shaker that enhanced dissolution. The absorbance was recorded using an ELISA reader at a reference wavelength of 570 and 630 nm [27].

2.8.4. Study of the Glucose Uptake of Hep-2 Cells through the Expression of 2-NBDG (2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl) Amino)-2-deoxyglucose)

Hep-2 cells were cultured in 96-well plates at a density of cells per 2 ml and incubated at 37°C overnight under a CO₂ atmosphere. After 24 hours, the spent media were aspirated, and the cells were added to a glucose-free culture medium containing 100 μM 2-NBDG and incubated for 2 hours with AgNPs. Metformin was used as the control. After the treatment, the medium was aspirated, and the cells were washed with PBS. PBS was removed, and 200 μl trypsin was added and incubated at 37°C for 3 to 4 minutes. After that, 2 ml of culture medium was added, and cells were harvested directly in tubes. The tubes were centrifuged for 5 minutes at 25°C at . The supernatant was carefully aspirated, and the pellet was resuspended with the cells in 0.5–1 ml of PBS. The entire tube was thoroughly mixed so that the cells would separate from each other. The cells were immediately analyzed by flow cytometry [28]. The fluorescence with excitation and emission at 465 nm and 540 nm, respectively, was measured in the FL1 channel used to detect FITC and utilized to examine the uptake of 2-NBDG by Hep-2 cells.

2.9. Statistical Analysis

Statistical evaluation of the results was analyzed through ; value was accepted as statistically significant.

3. Result and Discussion

3.1. Synthesis and Characterization of AgNPs

The reduction of silver nitrate into AgNPs occurs immediately after it comes into contact with the bacterial extract of Salmonella enterica (ATCC-14028). The dark brown solution confirms the reduction of silver nitrate (Figure 1) [29, 30]. AgNPs showed a specific absorption peak at 410 nm measured using the UV-Vis spectrophotometer, which validates the reduction of silver nitrate as shown in Figure 2 [31, 32]. Although a specific process for the reduction is unknown, some studies suggest that enzymes, such as NADH coenzyme reductase, are involved in the electron transfer (shuttle) to reduce or neutralize the Ag⁺ ions into nanoparticles [33, 34]. The biological approach used for the synthesis of various nanoparticles such as silver, gold, platinum, copper, cadmium, and zinc oxide showed excellent reduction and production of nanoparticles and contains various proteins and functional groups that stabilize the nanoparticles [35].

FTIR analysis showed that various functional groups are associated with AgNPs. The prominent functional groups are 3402.22 cm^-1 N-H stretch for amines and amides, 2962.66 cm^-1 C-H stretch, 2374.34 cm^-1 C-N stretch, 1653 cm^-1 C=O amide, 1458.18 cm^-1 C=O stretch, 1402.25 cm^-1 C=O stretch, and 1114.86 cm^-1 C-O primary alcohol, while FTIR for the bacterial extract showed the prominent peak at 3248.13 cm^-1 O-H stretch for carboxylic acid, 1633.71 cm^-1 C=C stretch alkene, 1450.47 cm^-1 C-H bend alkane, 1396.46 cm^-1 O-H bend phenol, 1330.88 cm^-1 C-N stretch amine, 1082.07 cm^-1 C-O stretch alcohol, and 1033.85 cm^-1 CO-O-CO stretch anhydride, and also, it showed some weak peaks associated with AgNPs as shown in Figure 3. Previous studies have revealed that the nanoparticles are attached to various functional groups and biomolecules such as carbohydrates, proteins, and phenols, which help to stabilize and reduce metal ions into nanoparticles [36, 37]. The peaks at 3402 cm^-1 and 1653 cm^-1 are due the carbonyl stretching of the proteins [38]. The presence of these functional groups such as amines, amides, alkanes, alkenes, and carbonyl groups enhances the stability and its biological efficacy [39].

(a)

(b)

The SEM analysis showed the surface morphology, whereas the EDX showed a prominent silver and silver purity peak (Figure 4). The morphology of the nanoparticles synthesized by the biological method differs from each other depending on reduction [40]. The SEM analysis showed that the nanoparticles are spherical in shape, while EDX showed a dominant peak of silver, which confirms the purity of silver and also confirms the presence of carbon and oxygen. The strong peak of silver is due to the absorption of silver, which corresponds to the plasmon surface resonance. Similar findings have been reported in the previous studies [41].

TEM confirms that the AgNPs are spherical in shape and are well dispersed without any agglomeration. Analysis of the TEM results confirmed that AgNPs are stable and their size ranges from 7.18 to 13.24 nm (Figure 5). Studies have shown that the shape and size of the nanoparticles have a significant impact on the antimicrobial action. The smaller the size of nanoparticles, the higher the efficacy [42]. When exposed for 30 minutes to sunlight LED (light-emitting diode), the AgNPs produced from the Dryopteris crassirhizoma rhizome extract also produced nanoparticles with sizes ranging from 5 to 60 nm. [43]. Our findings coincided with similar finding that biosynthesized AgNPs are spherical in shape, with no agglomeration [44]. The dispersion property of nanoparticles varies according to their shape, composition, and size [43].

Thermogravimetric analysis (TGA) confirmed the thermal stability, volatility, moisture, and oxidation content. Thermogram was used to measure the temperature of the dried AgNPs, which ranged from 30°C to 800°C. There was no significant loss of content at 100°C. The major protein loss occurs at 236°C due to volatilization as shown in Figure 6. According to a previous study, the protein’s thermal breakdown response ranges from 178°C to 288°C, depending on the purity and origin of the molecules [45]. At 782°C, the weight loss was 3.62 percent, with a final residual of 20.89 percent of the initial mass of AgNPs remaining in the sample pan, indicating that AgNPs are stable [46].

3.2. Antibacterial Effect of the AgNPs against MRSA and MRSE

The AgNPs were tested for their antibacterial effects against MRSA and MRSE. These AgNPs showed a minimum zone of inhibition at 10 μg/ml and a maximum zone of inhibition at 40 μg/ml against MRSA and MRSE. At a concentration of 40 μg/ml, the zone of inhibition of 17 mm was measured against MRSA, while the zone of inhibition for MRSE was 15 mm. For testing the synergistic effect against MRSA and MRSE, 20 μg/ml of AgNPs was impregnated on vancomycin (30 μg/disc), ceftriaxone (30 μg/disc), and gentamycin (30 μg/disc). Our study showed that vancomycin combined with AgNPs demonstrated a good zone of inhibition (29 mm) against MRSA, followed by gentamycin and ceftriaxone. Ceftriaxone, on the other hand, had a larger inhibition zone (34 mm), followed by Vancomycin and gentamycine for MRSE (Table 1 and Figure 7). The experiment was repeated thrice, and an average mean was calculated. Our findings support the previous research that silver nanoparticles have potent antibacterial properties against MRSA and MRSE [47].

The AgNP binds to the bacterial cell wall and produces changes in the membrane integrity hence disrupting the bacterial cell membrane. The disruption is owed to the interaction of AgNPs with the negative charge of the cell wall. The membrane disruption may lead to cell death [47]. Additionally, when the nanoparticles penetrate the cell, they generate oxidative stress, resulting in the production of reactive oxygen species (ROS), which causes mitochondrial damage, DNA intercalation, enzyme inhibition, and lipid peroxidation [48–51].

3.3. Antioxidant Activity of the AgNPs

The antioxidant activity of AgNPs was tested using the DPPH assay. The colour of the DPPH solution should change from purple to pale yellow, to confirm the antioxidant activity. This is due to the reduction of the DPPH radical via hydrogen atom transfer resulting in a pale-yellow solution [52]. Serially diluted solutions of 10, 20, 30, and 40 μg/ml of AgNPs were used for the DPPH assay. The absorbance was measured using the UV-Vis spectrophotometer, and ascorbic acid was used as a positive control. Our findings showed that AgNPs possess good antioxidant activity, and an increase in the concentration of AgNPs increases the antioxidant activity (Figure 8). Our findings are consistent with the previous research that reported AgNPs produced from plant extract had good radical scavenging capability [53].

3.4. Antidiabetic Activity

3.4.1. Inhibition of the Alpha-Amylase and Alpha-Glucosidase

The antidiabetic effect of biosynthesized AgNPs was assessed by measuring the activity of alpha-amylase and alpha-glucosidase. It was observed that AgNPs showed effective alpha-amylase inhibition at a concentration ranging from 62.5 to 1000 μg/ml. These AgNPs showed an IC50 at 428.60 μg/ml, compared to positive control acarbose which exhibited the IC50 at 295.42 μg/ml (Figures 9(a) and 9(b)). An earlier study demonstrated that silver nanoparticles synthesized from the plant Pterocarpus marsupium effectively inhibited the activity of the enzyme alpha-amylase [54].

(a)

(b)

AgNPs successfully suppressed alpha-glucosidase in a dose-dependent manner in the range of 62.5 to 1000 μg/ml. The statistical data through the ELISA plate reader revealed that AgNPs effectively inhibited alpha-glucosidase in a dose-dependent manner. The IC50 of AgNPs was 562.02 μg/ml, which was compared to the positive control voglibose (313.62 μg/ml) as shown in Figures 10(a) and 10(b).

(a)

(b)

Silver nanoparticles synthesized from grape pomace waste showed excellent inhibition of the alpha-amylase and alpha-glucosidase enzymes [55]. Silver nanoparticles synthesized from lemongrass also exhibited antidiabetic properties which were attributed to the inhibition of alpha-amylase in a dose-dependent manner [56]. Our results are supported with comparable findings in the published data [57].

3.4.2. Toxicity of the AgNPs on Hep-2 Liver Cancer Cells

The toxicity of AgNPs was carried out in Hep-2 liver cancer cells in a dose-dependent manner. The AgNP concentration varied as 10 μg/ml, 20 μg/ml, 40 μg/ml, 60 μg/ml, and 80 μg/ml, with positive control metformin at 100 μM, respectively. The biosynthesized AgNPs showed the IC50 at 80 μg/ml while at 40 μg/ml, more than 70% of the cells were alive and compared with the cells treated with metformin (Figures 11 and 12). Silver has shown excellent anticancer activity against various cancer cells such as MDA-MB-231 breast cancer cells, U251 glioblastoma cells, and IMR-90 lung fibroblasts in a dose-dependent manner [58–60]. These AgNPs showed excellent anticancer effects and can be a probable drug candidate for the anticancer drug delivery system [61]. These AgNPs produce ROS from oxidative stress depending on the size of the nanoparticles. The smaller the particle size, the higher the production of ROS [62]. AgNPs also induce mitochondrial disruption by leaking superoxide anion and reacting with the SH group of proteins and glutathione, resulting in oxidative stress [63, 64].

(a)

(b)

(c)

(d)

(e)

(f)

(g)

3.4.3. Study of the Glucose (2-NBDG) Uptake by Hep-G2 Cells Treated with AgNPs through Flow Cytometry

The glucose uptake of Hep-2 cells was assessed using 2-NBDG (2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino)-2-deoxyglucose)), a fluorescent deoxyglucose analog, and a fluorescent agent. Hep-2 cells were in glucose (2-NBDG) medium and treated with AgNPs 40 μg/ml (above 70% of cells are alive) along with a positive control, 100 μM of metformin (above 70% of cells are alive). Our results clearly showed that AgNP-treated Hep-2 cells enhanced glucose uptake by 62.3% while positive control showed 85.74% glucose uptake and untreated cells showed 0.12% through the expression of 2-NBDG by flow cytometry, as shown in Figures 13–15. Previous studies suggest that silver nanoparticles have good antidiabetic activity [65]. Silver nanoparticles synthesized from Halymenia poryphyroides possess excellent antidiabetic activity [66]. Herbal-mediated SNPs (HMSNPs) are nontoxic and safe and contain excellent antidiabetic properties at either a high or low concentration [67]. Silver nanoparticles synthesized from Tephrosia tinctoria possess good antidiabetic activity and improved glucose uptake in diabetic rats [68]. According to our findings, AgNPs stimulated uptake of glucose in Hep-2 cells, implying that they have excellent therapeutic and potential antidiabetic properties.

(a)

(b)

4. Conclusion

AgNPs produced by Salmonella enterica could be used as a reducing agent. The synthesized AgNPs are well dispersed, have limited or no agglomeration, and range in size from 7.18 nm to 13.24 nm. These AgNPs showed good synergistic antibacterial effects against MRSA and MRSE. In addition, the DPPH assay revealed that these AgNPs have significant antioxidant properties. These AgNPs were able to inhibit the alpha-amylase and alpha-glucosidase enzymes. Furthermore, these nanoparticles showed good toxicity towards Hep-2 cells. On the other hand, these AgNPs increase the absorption (uptake) of glucose treated (NBDG) in Hep-2 cells. We conclude that AgNPs synthesized from the bacterial extract exhibit excellent antibacterial, antioxidant, and antidiabetic activity and thus have the potential to be used in therapeutic applications. However, in vitro and in vivo research is needed considerably towards the toxicity and efficacy of these AgNPs on healthy human cells, which needs to be explored before using them as a strong therapeutic agent.

Data Availability

All the data used to support the findings of this study are included within the article.

Conflicts of Interest

There is no potential conflict of interest among authors.

Acknowledgments

The authors would like thank Faculty of Pharmacy and Health Science, Universiti Kuala Lumpur Royal College of Medicine Perak (UniKL-RCMP), and Bioresource Technology, School of Industrial Technology, Universiti Sains Malaysia, for providing the necessary facilities to carry this study. This work was funded by the Researchers Supporting Project number (RSP-2021/26), King Saud University, Riyadh, Saudi Arabia.

References

M. Darroudi, M. B. Ahmad, A. H. Abdullah, and N. A. Ibrahim, “Green synthesis and characterization of gelatin-based and sugar-reduced silver nanoparticles,” International Journal of Nanomedicine, vol. 6, pp. 569–574, 2011.
View at: Publisher Site | Google Scholar
J. Xu, X. Xiao, F. Ren et al., “Enhanced photocatalysis by coupling of anatase TiO2 film to triangular Ag nanoparticle island,” Nanoscale Research Letters, vol. 7, no. 1, p. 239, 2012.
View at: Publisher Site | Google Scholar
D. I. Gittins, D. Bethell, D. J. Schiffrin, and R. J. Nichols, “A nanometre-scale electronic switch consisting of a metal cluster and redox-addressable groups,” Nature, vol. 408, no. 6808, pp. 67–69, 2000.
View at: Publisher Site | Google Scholar
Y. Shiraishi and N. Toshima, “Oxidation of ethylene catalyzed by colloidal dispersions of poly(sodium acrylate)-protected silver nanoclusters,” Colloids and Surfaces A: Physicochemical and Engineering Aspects, vol. 169, no. 1-3, pp. 59–66, 2000.
View at: Publisher Site | Google Scholar
W. R. Li, X. B. Xie, Q. S. Shi, H. Y. Zeng, Y. S. Ou-Yang, and Y. B. Chen, “Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli,” Applied Microbiology and Biotechnology, vol. 85, no. 4, pp. 1115–1122, 2010.
View at: Publisher Site | Google Scholar
P. Mukherjee, A. Ahmad, D. Mandal et al., “Fungus-mediated synthesis of silver nanoparticles and their immobilization in the mycelial matrix: a novel biological approach to nanoparticle synthesis,” Nano Letters, vol. 1, no. 10, pp. 515–519, 2001.
View at: Publisher Site | Google Scholar
S. Chernousova and M. Epple, “Silver as antibacterial agent: ion, nanoparticle, and metal,” Angewandte Chemie, International Edition, vol. 52, no. 6, pp. 1636–1653, 2013.
View at: Publisher Site | Google Scholar
V. K. Sharma, R. A. Yngard, and Y. Lin, “Silver nanoparticles: green synthesis and their antimicrobial activities,” Advances in Colloid and Interface Science, vol. 145, no. 1-2, pp. 83–96, 2009.
View at: Publisher Site | Google Scholar
S. Viswanathan, T. Palaniyandi, R. Shanmugam, B. K. Rajendran, and A. Sivaji, “Biomedical potential of silver nanoparticles capped with active ingredients of Hypnea valentiae, red algae species,” Particulate Science and Technology, pp. 1–11, 2021.
View at: Publisher Site | Google Scholar
D. Soumya and B. Srilatha, “Late stage complications of diabetes and insulin resistance,” Journal of Diabetes & Metabolism, vol. 2, article 1000167, 2011.
View at: Publisher Site | Google Scholar
E. Saedi, M. R. Gheini, F. Faiz, and M. A. Arami, “Diabetes mellitus and cognitive impairments,” World Journal of Diabetes, vol. 7, no. 17, pp. 412–422, 2016.
View at: Publisher Site | Google Scholar
G. Arumugam, P. Manjula, and N. Paari, “A review: anti diabetic medicinal plants used for diabetes mellitus,” Journal of Acute Disease, vol. 2, no. 3, pp. 196–200, 2013.
View at: Publisher Site | Google Scholar
S. E. Inzucchi, “Oral antihyperglycemic therapy for type 2 diabetes,” Journal of the American Medical Association, vol. 287, no. 3, pp. 360–372, 2002.
View at: Publisher Site | Google Scholar
L. Dey, A. S. Attele, and C. S. Yuan, “Alternative therapies for type 2 diabetes,” Alternative Medicine Review, vol. 7, no. 1, pp. 45–58, 2002.
View at: Google Scholar
W. L. Bennett, N. M. Maruthur, S. Singh et al., “Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations,” Annals of Internal Medicine, vol. 154, no. 9, pp. 602–613, 2011.
View at: Publisher Site | Google Scholar
K. M. Bratlie, R. L. York, M. A. Invernale, R. Langer, and D. G. Anderson, “Materials for diabetes therapeutics,” Advanced Healthcare Materials, vol. 1, no. 3, pp. 267–284, 2012.
View at: Publisher Site | Google Scholar
L. Bahshi, R. Freeman, R. Gill, and I. Willner, “Optical detection of glucose by means of metal nanoparticles or semiconductor quantum dots,” Small, vol. 5, no. 6, pp. 676–680, 2009.
View at: Publisher Site | Google Scholar
V. Ravaine, C. Ancla, and B. Catargi, “Chemically controlled closed-loop insulin delivery,” Journal of Controlled Release, vol. 132, no. 1, pp. 2–11, 2008.
View at: Publisher Site | Google Scholar
Paclitaxel (Abraxane), U.S. Food and Drug Administration, 2012.
E. A. Martis, R. R. Badve, and M. D. Degwekar, “Nanotechnology based devices and applications in medicine: an overview,” Chronicles of Young Scientists, vol. 3, no. 1, pp. 68–73, 2012.
View at: Publisher Site | Google Scholar
R. Zamiri, B. Z. Azmi, A. R. Sadrolhosseini, H. A. Ahangar, A. W. Zaidan, and M. A. Mahdi, “Preparation of silver nanoparticles in virgin coconut oil using laser ablation,” International Journal of Nanomedicine, vol. 6, pp. 71–75, 2011.
View at: Publisher Site | Google Scholar
J. P. Abid, A. W. Wark, P. F. Brevet, and H. H. Girault, “Preparation of silver nanoparticles in solution from a silver salt by laser irradiation,” Chemical Communications, vol. 7, no. 7, pp. 792-793, 2002.
View at: Publisher Site | Google Scholar
N. Aziz, M. Faraz, R. Pandey et al., “Facile algae-derived route to biogenic silver nanoparticles: synthesis, antibacterial, and photocatalytic properties,” Langmuir, vol. 31, no. 42, pp. 11605–11612, 2015.
View at: Publisher Site | Google Scholar
Q. Ahmed, N. Gupta, A. Kumar, and S. Nimesh, “Antibacterial efficacy of silver nanoparticles synthesized employing Terminalia arjunabark extract,” Artificial Cells, Nanomedicine, and Biotechnology, vol. 45, no. 6, pp. 1192–1200, 2017.
View at: Publisher Site | Google Scholar
R. G. Saratale, H. S. Shin, G. Kumar et al., “Exploiting fruit byproducts for eco-friendly nanosynthesis: citrus × clementina peel extract mediated fabrication of silver nanoparticles with high efficacy against microbial pathogens and rat glial tumor C6 cells,” Environmental Science and Pollution Research, vol. 25, no. 11, pp. 10250–10263, 2017.
View at: Publisher Site | Google Scholar
R. Manikandan, A. V. Anand, S. Kumar, and P. Pushpa, “Phytochemical and in vitro antidiabetic activity of Psidium guajava leaves,” Pharmacognosy Journal, vol. 8, no. 4, pp. 392–394, 2016.
View at: Publisher Site | Google Scholar
M. C. Alley, D. A. Scudiere, A. Monks, M. Czerwinski, R. Shoemaker II., and M. R. Boyd, “Validation of an automated microculture tetrazolium assay (MTA) to assess growth and drug sensitivity of human tumor cell lines,” Proceedings of the American Association for Cancer Research, vol. 27, p. 389, 1986.
View at: Google Scholar
“Invitrogen,” https://www.lifetechnologies.com/order/catalog/product/N13195.
View at: Google Scholar
G. A. Martinez-Castanon, N. Nino-Martinez, F. Martinez-Gutierrez, J. R. Martinez-Mendoza, and F. Ruiz, “Synthesis and antibacterial activity of silver nanoparticles with different sizes,” Journal of Nanoparticle Research, vol. 10, no. 8, pp. 1343–1348, 2008.
View at: Publisher Site | Google Scholar
S. Majeed, M. S. bin Abdullah, G. K. Dash, M. T. Ansari, and A. Nanda, “Biochemical synthesis of silver nanoprticles using filamentous fungi Penicillium decumbens (MTCC-2494) and its efficacy against A-549 lung cancer cell line,” Chinese Journal of Natural Medicines, vol. 14, no. 8, pp. 615–620, 2016.
View at: Publisher Site | Google Scholar
F. Baghbani-Arani, R. Movagharnia, A. Sharifian, S. Salehi, and S. A. S. Shandiz, “Photo-catalytic, anti-bacterial, and anti-cancer properties of phyto-mediated synthesis of silver nanoparticles from Artemisia tournefortiana Rchb extract,” Journal of Photochemistry and Photobiology B: Biology, vol. 173, pp. 640–649, 2017.
View at: Google Scholar
M. Khoshnamv, C. Huo, and J. Liu, “Silver nanoparticles synthesized using Allium ampeloprasum L. leaf extract: characterization and performance in catalytic reduction of 4-nitrophenol and antioxidant activity,” Journal of Molecular Structure, vol. 1175, no. 5, pp. 90–96, 2019.
View at: Publisher Site | Google Scholar
Y. Roh, J. Bai, R. J. Lauf, A. D. Mcmillan, T. J. Phelps, and C. J. Rawn, “Microbial synthesis of metal-substituted magnetites,” Solid State Communications, vol. 11, pp. 529–534, 2001.
View at: Publisher Site | Google Scholar
M. Labrenz, G. K. Druschel, T. Thomsen-Ebert et al., “Formation of sphalerite (ZnS) deposits in natural biofilms of sulfate-reducing bacteria,” Science, vol. 1, pp. 744–747, 2000.
View at: Publisher Site | Google Scholar
Y. K. Mohanta, A. Hashem, E. F. A. Allah, S. K. Jena, and T. K. Mohanta, “Bacterial synthesized metal and metal salt nanoparticles in biomedical applications: an up and coming approach,” Applied Organometallic Chemistry, vol. 34, no. 9, 2020.
View at: Publisher Site | Google Scholar
P. Devaraj, P. Kumari, C. Aarti, and A. Renganathan, “Synthesis and characterization of silver nanoparticles using cannonball leaves and their cytotoxic activity against MCF-7 cell line,” Journal of Nanotechnology, vol. 2013, Article ID 598328, 5 pages, 2013.
View at: Publisher Site | Google Scholar
V. Arya, “Vedpriya living systems: eco-friendly nanofactories digest,” Digest Journal of Nanomaterials & Biostructures (DJNB), vol. 5, no. 1, p. 9, 2010.
View at: Google Scholar
M. Vivek, P. S. Kumar, S. Steffi, and S. Sudha, “Biogenic silver nanoparticles by Gelidiella acerosa extract and their antifungal effects,” Avicenna Journal of Medical Biotechnology, vol. 3, no. 3, pp. 143–148, 2011.
View at: Google Scholar
S. Ravichandran, V. Paluri, G. Kumar, K. Loganathan, and B. R. KokatiVenkata, “A novel approach for the biosynthesis of silver oxide nanoparticles using aqueous leaf extract of Callistemon lanceolatus (Myrtaceae) and their therapeutic potential,” Journal of Experimental Nanoscience, vol. 11, no. 6, pp. 445–458, 2016.
View at: Publisher Site | Google Scholar
K. Kalimuthu, R. S. Babu, D. Venkataraman, M. Bilal, and S. Gurunathan, “Biosynthesis of silver nanocrystals by Bacillus licheniformis,” Colloids and Surfaces. B, Biointerfaces, vol. 65, no. 1, pp. 150–153, 2008.
View at: Publisher Site | Google Scholar
R. Manikandan, B. Manikandan, T. Raman et al., “Biosynthesis of silver nanoparticles using ethanolic petals extract of Rosa indica and characterization of its antibacterial, anticancer and anti-inflammatory activities,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, vol. 138, pp. 120–129, 2015.
View at: Publisher Site | Google Scholar
C. Ramteke, T. Chakrabarti, B. K. Sarangi, and R. A. Pandey, “Pandey synthesis of silver nanoparticles from the aqueous extract of leaves of Ocimum sanctum for enhanced antibacterial activity,” Journal of Chemistry, vol. 2013, Article ID 278925, 7 pages, 2013.
View at: Publisher Site | Google Scholar
J. H. Lee, J. M. Lim, P. Velmurugan et al., “Photobiologic-mediated fabrication of silver nanoparticles with antibacterial activity,” Journal of Photochemistry and Photobiology B: Biology, vol. 162, pp. 93–99, 2016.
View at: Publisher Site | Google Scholar
C. G. Castro-González, L. Sánchez-Segura, F. C. Gómez-Merino, and J. J. Bello-Bello, “Exposure of stevia (Stevia rebaudiana B.) to silver nanoparticles in vitro: transport and accumulation,” Scientific Reports, vol. 9, no. 1, pp. 1–10, 2019.
View at: Publisher Site | Google Scholar
L. Ricci, E. Umiltà, M. C. Righetti et al., “On the thermal behavior of protein isolated from different legumes investigated by DSC and TGA,” Journal of the Science of Food and Agriculture, vol. 98, no. 14, pp. 5368–5377, 2018.
View at: Publisher Site | Google Scholar
S. Majeed, F. H. B. Aripin, N. S. B. Shoeb, M. Danish, M. N. M. Ibrahim, and R. Hashim, “Bioengineered silver nanoparticles capped with bovine serum albumin and its anticancer and apoptotic activity against breast, bone and intestinal colon cancer cell lines,” Materials Science and Engineering: C, vol. 102, pp. 254–263, 2019.
View at: Publisher Site | Google Scholar
A. Nanda and M. Saravanan, “Biosynthesis of silver nanoparticles from Staphylococcus aureus and its antimicrobial activity against MRSA and MRSE,” Nanomedicine : nanotechnology, biology, and medicine., vol. 5, no. 4, pp. 452–456, 2009.
View at: Publisher Site | Google Scholar
M. Yamanaka, K. Hara, and J. Kudo, “Bactericidal actions of a silver ion solution on Escherichia coli, studied by energy-filtering transmission electron microscopy and proteomic analysis,” Applied and Environmental Microbiology, vol. 71, no. 11, pp. 7589–7593, 2005.
View at: Publisher Site | Google Scholar
J. S. Ali, A. Mannan, M. Nasrullah, H. Ishtiaq, S. Naz, and M. Zia, “Antimicrobial, antioxidative, and cytotoxic properties of Monotheca buxifolia assisted synthesized metal and metal oxide nanoparticles,” Inorganic and Nano-Metal Chemistry, vol. 50, no. 9, pp. 770–782, 2020.
View at: Publisher Site | Google Scholar
A. Gour and N. K. Jain, “Advances in green synthesis of nanoparticles,” Artificial Cells, Nanomedicine, and Biotechnology, vol. 47, no. 1, pp. 844–851, 2019.
View at: Publisher Site | Google Scholar
N. Von Moos and V. I. Slaveykova, “Oxidative stress-induced by inorganic nanoparticles in bacteria and aquatic microalgae–state of the art and knowledge gaps,” Nanotoxicology, vol. 8, no. 6, pp. 605–630, 2013.
View at: Publisher Site | Google Scholar
K. Sirivibulkovit, S. Nouanthavong, and Y. Sameenoi, “Paper-based DPPH assay for antioxidant activity analysis,” Analytical Sciences, vol. 34, no. 7, pp. 795–800, 2018.
View at: Publisher Site | Google Scholar
M. K. Swamy, K. M. Sudipt, K. Jayant, and S. Balasubramany, “The green synthesis, characterization, and evaluation of the biological activities of silver nanoparticles synthesized from Leptadenia reticulata leaf extract,” Applied Nanoscience, vol. 5, no. 1, pp. 73–81, 2014.
View at: Publisher Site | Google Scholar
J. Bagyalakshmi and H. Haritha, “Green synthesis and characterization of silver nanoparticles using Pterocarpus marsupium and assessment of its in vitro antidiabetic activity,” American Journal of Advanced Drug Delivery, vol. 5, pp. 118–130, 2017.
View at: Publisher Site | Google Scholar
G. D. Saratale, R. G. Saratale, D.-S. Kim, D.-Y. Kim, and H.-S. Shin, “Exploiting fruit waste grape pomace for silver nanoparticles synthesis, assessing their antioxidant, antidiabetic potential and antibacterial activity against human pathogens: a novel approach,” Nanomaterials, vol. 10, p. 1457, 2020.
View at: Publisher Site | Google Scholar
H. Agarwal, S. V. Kumar, and S. Rajeshkumar, “Antidiabetic effect of silver nanoparticles synthesized using lemongrass (Cymbopogon citratus) through conventional heating and microwave irradiation approach,” Journal of Microbiology, Biotechnology and Food Sciences, vol. 7, pp. 371–376, 2018.
View at: Publisher Site | Google Scholar
E. Mikhailova, “Silver nanoparticles: mechanism of action and probable bio-application. Journal of Functional,” Journal of Functional Biomaterials, vol. 11, no. 4, p. 84, 2020.
View at: Publisher Site | Google Scholar
S. Gurunathan, J. Raman, S. N. A. Malek, P. A. John, and S. Vikineswary, “Green synthesis of silver nanoparticles using Ganoderma neo-japonicumImazeki: a potential cytotoxic agent against breast cancer cells,” International Journal of Nanomedicine, vol. 8, p. 4399, 2013.
View at: Publisher Site | Google Scholar
A. Mishra, S. J. Mehdi, M. Irshad et al., “Effect of biologically synthesized silver nanoparticles on human cancer cells,” Science of Advanced Materials, vol. 4, pp. 1200–1206, 2012.
View at: Publisher Site | Google Scholar
A. A. Kajani, A.-K. Bordbar, S. H. Z. Esfahani, A. R. Khosropour, and A. Razmjou, “Green synthesis of anisotropic silver nanoparticles with potent anticancer activity using Taxusbaccata extract,” RSC Advances, vol. 4, pp. 61394–61403, 2014.
View at: Publisher Site | Google Scholar
V. S. Madamsetty, A. Mukherjee, and S. Mukherjee, “Recent trends of the bio-inspired nanoparticles in cancer theranostics,” Frontiers in Pharmacology, vol. 10, p. 1264, 2019.
View at: Publisher Site | Google Scholar
K. B. R. Ahmed, A. M. Nagy, R. P. Brown, Q. Zhang, S. G. Malghan, and P. L. Goering, “Silver nanoparticles: significance of physicochemical properties and assay interference on the interpretation of in vitro cytotoxicity studies,” Toxicology in Vitro, vol. 38, pp. 179–192, 2017.
View at: Publisher Site | Google Scholar
M. Konieczna and D. Hudy, “Biological activity of silver nanoparticles and their applications in anticancer therapy,” Silver Nanoparticles - Fabrication, Characterization and Applications, vol. 131, 2018.
View at: Publisher Site | Google Scholar
L. K. Braydich-Stolle, B. Lucas, A. Schrand et al., “Silver nanoparticles disrupt GDNF/Fyn kinase signaling in spermatogonial stem cells,” Toxicological Sciences, vol. 116, pp. 577–589, 2010.
View at: Publisher Site | Google Scholar
R. G. Saratale, H. S. Shin, G. Kumar, G. Benelli, D. S. Kim, and G. D. Saratale, “Exploiting antidiabetic activity of silver nanoparticles synthesized using Punica granatum leaves and anticancer potential against human liver cancer cells (HepG2),” Artificial Cells, Nanomedicine, and Biotechnology, vol. 46, no. 1, pp. 211–222, 2018.
View at: Publisher Site | Google Scholar
D. Manam, V. Kiran, and S. Murugesan, “Biogenic silver nanoparticles by Halymeniaporyphyroides and its in vitro anti-diabetic efficacy,” Journal of Chemical and Pharmaceutical Research, vol. 5, pp. 1001–1008, 2013.
View at: Google Scholar
K. Shanker, G. K. Mohan, A. Hussain, N. Jayarambabu, and P. L. Pravallika, “Green biosynthesis, characterization, in vitro antidiabetic activity, and investigational acute toxicity studies of some herbal-mediated silver nanoparticles on animal models,” Pharmacognosy Magazine, vol. 13, pp. 188–192, 2017.
View at: Publisher Site | Google Scholar
K. Rajaram, D. C. Aiswarya, and P. Sureshkumar, “Green synthesis of silver nanoparticle using Tephrosia tinctoria and its antidiabetic activity,” Materials Letters, vol. 138, pp. 251–254, 2015.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2022 Shahnaz Majeed et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1396

Downloads

796

Citations